Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
1.782
-0.030 (-1.66%)
At close: Apr 28, 2026
-14.33%
Market Cap 1.20B
Revenue (ttm) 660.04M
Net Income (ttm) 51.77M
Shares Out 671.34M
EPS (ttm) 0.08
PE Ratio 23.11
Forward PE n/a
Dividend 0.04 (1.97%)
Ex-Dividend Date Oct 1, 2026
Volume 200,225
Average Volume 304,485
Open 1.814
Previous Close 1.812
Day's Range 1.782 - 1.836
52-Week Range 1.750 - 2.725
Beta 0.28
RSI 34.12
Earnings Date May 27, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,356
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2025, Antibiotice's revenue was 660.04 million, a decrease of -4.16% compared to the previous year's 688.70 million. Earnings were 51.77 million, a decrease of -49.35%.

Financial Statements

News

There is no news available yet.